Cardinal Subpoenaed By DEA, DOJ Over Drug Diversion

Law360, New York (August 22, 2012, 3:38 PM EDT) -- Cardinal Health Inc. on Wednesday said it was responding to civil subpoenas from the U.S. Department of Justice and U.S. Drug Enforcement Administration, following a settlement with the DEA over allegations that the drug distributor had filled suspicious orders for painkiller oxycodone.

According to Cardinal's statement in a quarterly report filed with the U.S. Securities and Exchange Commission, while the company had previously accepted a two-year ban on shipping prescription drugs from its Florida distribution center and enhanced its oversight procedures to settle the DEA’s allegations...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.